Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Drug Metabolism and Pharmacokinetics|July 6, 2011
Correlation of intrinsic in vitro and in vivo clearance for drugs metabolized by hepatic UDP-glucuronosyltransferases in ratsFumihiro Nakamori, Yoichi Naritomi, Masako Furutani, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 22, 2013
Species differences in intestinal glucuronidation activities between humans, rats, dogs and monkeysTakako Furukawa, Yoichi Naritomi, Kazuhiro Tetsuka, et al.
Bioanalysis|January 9, 2023
Understanding quantitative polymerase chain reaction bioanalysis issues before validation planning: Japan Bioanalysis Forum discussion groupAsako Uchiyama, Yoichi Naritomi, Yoshitaka Hashimoto, et al.
Bioorganic & Medicinal Chemistry|July 13, 2013
Discovery of 2-methyl-1-{1-[(5-methyl-1H-indol-2-yl)carbonyl]piperidin-4-yl}propan-2-ol: a novel, potent and selective type 5 17β-hydroxysteroid dehydrogenase inhibitorKazushi Watanabe, Akio Kakefuda, Minoru Yasuda, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 12, 2012
Quantitative prediction of human intestinal glucuronidation effects on intestinal availability of UDP-glucuronosyltransferase substrates using in vitro dataFumihiro Nakamori, Yoichi Naritomi, Ken-Ichi Hosoya, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 4, 2015
Predictability of plasma concentration-time curves in humans using single-species allometric scaling of chimeric mice with humanized liverSeigo Sanoh, Yoichi Naritomi, Mami Fujimoto, et al.
British Journal of Pharmacology|January 13, 2005
Prevention of progressive joint destruction in collagen-induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR255031Takeshi Ishikawa, Fusako Nishigaki, Susumu Miyata, et al.
Cancer Immunology, Immunotherapy : CII|March 31, 2026
An innovative treatment for lung cancer using gene-engineered human-induced pluripotent stem cell-derived natural killer cellsYuka Sato, Kumiko Goto, Shigehiro Yagishita, et al.
Regenerative Therapy|July 26, 2021
Biodistribution studies for cell therapy products: Current status and issuesYoshiteru Kamiyama, Yoichi Naritomi, Yuu Moriya, et al.
Stem Cell Research & Therapy|July 14, 2025
Human iPSC-derived NK cells armed with CCL19, CCR2B, high-affinity CD16, IL-15, and NKG2D complex enhance anti-solid tumor activityYuma Fukutani, Kenji Kurachi, Yu-Suke Torisawa, et al.
Pageof 2